Ocular Therapeutix (OCUL) Earnings Date, Estimates & Call Transcripts $9.92 -0.68 (-6.42%) (As of 04:32 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ocular Therapeutix Latest Earnings SummaryLatest Earnings DateNov. 14ConfirmedActual EPS (Nov. 14) -$0.22 Beat By $0.01 Consensus EPS (Nov. 14) -$0.23 Ocular Therapeutix released Q3 2024 earnings on November 14, 2024, reporting an EPS of -$0.22, which topped the consensus estimate of -$0.23 by $0.01. Quarterly revenue rose 2.0% year-over-year to $15.40 million, below analysts' expectations of $17.13 million. With a trailing EPS of -$1.35, Ocular Therapeutix's earnings are expected to grow next year, from ($1.02) to ($0.97) per share. Conference Call AudioOCUL Upcoming EarningsOcular Therapeutix's next earnings date is scheduled for Thursday, November 14, 2024. Get Ocular Therapeutix Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ocular Therapeutix and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOCUL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OCUL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Ocular Therapeutix Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.16-$0.16-$0.16Q2 20241-$0.14-$0.14-$0.14Q3 20241-$0.13-$0.13-$0.13Q4 20241-$0.13-$0.13-$0.13FY 20244-$0.56-$0.56-$0.56Q1 20251-$0.14-$0.14-$0.14Q2 20251-$0.14-$0.14-$0.14Q3 20251-$0.14-$0.14-$0.14Q4 20251-$0.13-$0.13-$0.13FY 20254($0.55)($0.55)($0.55) Ocular Therapeutix Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks11/14/2024--$0.23-$0.22+$0.01-$17.13M$15.40M 8/7/2024Q2 2024-$0.22-$0.26 -$0.04-$0.22$15.85M$16.40M 5/7/2024Q1 2024-$0.18-$0.24 -$0.06$0.01$15.43M$14.77M 3/11/2024Q4 2023-$0.28-$0.28--$0.21$15.31M$14.80M 11/7/2023Q3 2023-$0.27-$0.51 -$0.24-$0.77$15.41M$15.08M 8/7/2023Q2 2023-$0.29-$0.27+$0.02-$0.28$14.64M$15.19M Get the Latest News and Ratings for OCUL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocular Therapeutix and its competitors with MarketBeat's FREE daily newsletter. 5/8/2023Q1 2023-$0.27-$0.31 -$0.04-$0.23$14.02M$13.37M 3/6/2023Q4 2022-$0.25-$0.24+$0.01-$0.24$13.60M$14.08M Ocular Therapeutix Earnings - Frequently Asked Questions When is Ocular Therapeutix's earnings date? Ocular Therapeutix has confirmed that its next quarterly earnings data will be published on Thursday, November 14th, 2024. Learn more on OCUL's earnings history. Did Ocular Therapeutix beat their earnings estimates last quarter? In the previous quarter, Ocular Therapeutix (NASDAQ:OCUL) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.01. Learn more on analysts' earnings estimate vs. OCUL's actual earnings. How can I listen to Ocular Therapeutix's earnings conference call? The conference call for Ocular Therapeutix's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Ocular Therapeutix generate each year? Ocular Therapeutix (NASDAQ:OCUL) has a recorded annual revenue of $61.10 million. How much profit does Ocular Therapeutix generate each year? Ocular Therapeutix (NASDAQ:OCUL) has a recorded net income of -$80.74 million. OCUL has generated -$1.35 earnings per share over the last four quarters. What is Ocular Therapeutix's EPS forecast for next year? Ocular Therapeutix's earnings are expected to grow from ($1.02) per share to ($0.97) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Kiniksa Pharmaceuticals Earnings Supernus Pharmaceuticals Earnings Arcutis Biotherapeutics Earnings Innoviva Earnings Phathom Pharmaceuticals Earnings Pliant Therapeutics Earnings Theravance Biopharma Earnings Karyopharm Therapeutics Earnings Cytokinetics Earnings Blueprint Medicines Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide This page (NASDAQ:OCUL) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocular Therapeutix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocular Therapeutix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
